Trial NCT01220128

View at ClinicalTrials.gov 
Org. Study IDs: 113172
Secondary IDs: 2010-019909-42

Last trial update was posted on 2021-05-25

MeSH Interventions

Aromatase Inhibitors Carboplatin Cyclophosphamide Docetaxel Doxorubicin Epirubicin Fluorouracil Paclitaxel Trastuzumab

MeSH Conditions

Breast Neoplasms

Other Conditions

Neoplasms, Breast

Stopping Reasons

Study termination due to negative Ph III of another study product from same technology platform.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID